NONMYELOABLATIVE HLA-HAPLOIDENTICAL BONE MARROW TRANSPLANTATION (HAPLO-BMT) WITH POST-TRANSPLANT HIGH-DOSE CYCLOPHOSPHAMIDE (CY) IN PATIENTS WITH SEVERE HEMOGLOBINOPATHIES

被引：2
|
作者：
Bolanos-Meade, J. [1 ]
Lanzkron, S. [1 ]
Kemberling, H. [1 ]
Gamper, C. [1 ]
Ambinder, R. F. [1 ]
Luznik, L. [1 ]
Luznik, E. J. [1 ]
Jones, R. J. [1 ]
Brodsky, R. A. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.399
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
363
引用
收藏
页码：S285 / S285
页数：1
相关论文
共 50 条
  • [21] The Fountain of Youth: Outcomes of Nonmyeloablative (NMA), HLA-Haploidentical Related (Haplo) Bone Marrow Transplantation (BMT) with Post-Transplantation Cyclophosphamide (PTCy) Best with Younger Donors Regardless of Relationship to Patient
    Franklin, Clio E.
    Showel, Margaret M.
    Tsai, Hua-Ling
    Varadhan, Ravi
    McCurdy, Shannon R.
    Gladstone, Douglas E.
    Jones, Richard J.
    DeZern, Amy E.
    [J]. BLOOD, 2017, 130
  • [22] Nonmyeloablative HLA-Haploidentical (NMA Haplo) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Is Associated with Similar Outcomes to Matched BMT When Stratified By Disease Risk Index (DRI)
    McCurdy, Shannon R.
    Kanakry, Jennifer A.
    Showel, Margaret M.
    Tsai, Hua-Ling
    Bolanos-Meade, Javier
    Kanakry, Christopher G.
    Gladstone, Douglas E.
    Luznik, Leo
    Huff, Carol Ann
    Swinnen, Lode J.
    Ambinder, Richard F.
    Jones, Richard J.
    Fuchs, Ephraim J.
    Kasamon, Yvette L.
    [J]. BLOOD, 2014, 124 (21)
  • [23] Use of G-CSF mobilized bone marrow grafts in HLA-haploidentical related bone marrow transplantation (BMT) with post-transplantation cyclophosphamide (PT-CY)
    Nadira, D.
    Brian, M. J.
    Zinaida, P.
    Lana, D.
    Alen, O.
    Zorana, G.
    Ranka, S. S.
    Radovan, V.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S147 - S148
  • [24] High-dose cyclophosphamide (Cy) without bone marrow transplant (BMT) for refractory severe autoimmune diseases (SADS).
    Brodsky, RA
    Smith, BD
    Brodsky, I
    Anhalt, G
    Petri, M
    Jones, RJ
    [J]. BLOOD, 1997, 90 (10) : 1028 - 1028
  • [25] High-dose cyclophosphamide (CY) without bone marrow transplant (BMT) for refractory severe autoimmune diseases (SADS).
    Petri, M
    Jones, RJ
    Smith, BD
    Brodsky, I
    Anhalt, G
    Brodsky, RA
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S242 - S242
  • [26] Shortened-Duration Tacrolimus after Nonmyeloablative HLA-Haploidentical (NMA haplo) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Facilitates Strategies for Relapse Reduction
    Kasamon, Yvette L.
    Fuchs, Ephraim J.
    Zahurak, Marianna
    Rosner, Gary L.
    Symons, Heather J.
    Bolanos-Meade, Javier
    Jones, Richard J.
    [J]. BLOOD, 2016, 128 (22)
  • [27] Using Haploidentical (haplo) Donors and High-Dose Post-Transplant Cyclophosphamide (PTCy) for Refractory Severe Aplastic Anemia (SAA)
    DeZern, Amy E.
    Dorr, Donna
    Luznik, Leo
    Bolanos-Meade, Javier
    Gamper, Christopher
    Symons, Heather J.
    Cooke, Kenneth R.
    Jones, Richard J., Sr.
    Brodsky, Robert A.
    [J]. BLOOD, 2015, 126 (23)
  • [28] Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
    Luznik, Leo
    O'Donnell, Paul V.
    Fuchs, Ephraim J.
    [J]. SEMINARS IN ONCOLOGY, 2012, 39 (06) : 683 - 693
  • [29] Use of G-CSF Mobilized Bone Marrow Grafts in HLA-haploidentical Bone Marrow Transplantation (BMT) with Post-transplantation Cyclophosphamide (PT-Cy) Decreases Risk of Severe Acute GVHD
    Durakovic, Nadira
    Peric, Zinaida
    Desnica, Lana
    Grubic, Zorana
    Romic, Lucija
    Serventi-Seiwerth, Ranka
    Vrhovac, Radovan
    [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 707 - 708
  • [30] Related Nonmyeloablative Haploidentical (mini-haplo) Blood or Marrow Transplantation (BMT) with High-Dose Post-Transplant Cyclophosphmade (PTCy) for Acute Myeloid Leukemia (AML): Donor Age Impacts Outcome
    Showel, Margaret M.
    Fuchs, Ephraim J.
    Varadhan, Ravi
    Levis, Mark J.
    Jones, Richard J.
    [J]. BLOOD, 2015, 126 (23)
12345